These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: The business case for medication safety.
    Author: Kinninger T, Reeder L.
    Journal: Healthc Financ Manage; 2003 Feb; 57(2):46-51. PubMed ID: 12602311.
    Abstract:
    The decision to invest in a medication-safety system should take into account not only implementation costs but also reduced hospital costs for treating complications resulting from medication errors and potential liability. Medication-safety programs should be analyzed and planned the same as any other investment. Providers should base their projected return from a medication-safety system on intangible benefits to the organization as well as an ROI calculation. Investment in medication-safety systems can be justified in terms of risk management and legal liability.
    [Abstract] [Full Text] [Related] [New Search]